维普中文期刊产品整合服务
7篇 您的检索式:作者名="Noel AR"
    题名 作者 年代 出处 被引量
1In vitro activities of nine peptide deformylase inhibitors and five comparator agents against respiratory and skin pathogens 显示文摘Bowker KE Noel AR MacGowan AP 2003Int J Antimicrob Agent2003,22,6:1
2Correlation and prognostic significance of p53,p21and ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intrvesil therapy显示文摘Zlotta AR Noel JC Fayt L 1999J Urol1999,161,:1
3Correlation and prognostic significanoe of p53, p21and ki -67 expression in pationts with superficial bladder tumors treated with bacillus Calmette - Guerin intrvesil therapy显示文摘Zlotta AR Noel JC Fayt L 1999J Uml1999,161,:1
4Activity of AZD2563,a novel oxazolidinone,against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid显示文摘HOWE RA WOOTTON M NOEL AR 2003Antimicrob Agents Chemother2003,47,11:1
5Pharmacodynamics of ceftazidime plus the serine fl-lactamase inhibitor AM-112 against Escherichia coli containing TEM-1 and CTX-M-1 fl- lactamases 显示文摘Bowker KE Noel AR Walsh TR 2004Antimicrob Agents Chemother2004,48,:1
6Radiographic imaging for the cochlear implant显示文摘Richard AR Noel LC Peborah LR 1987Ann Rhinol Laryngol1987,96,31:1
7Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy:Role of faecal immunochemical test显示文摘BACKGROUND Faecal immunochemical test(FIT)has been recommended to assess symptomatic patients for colorectal cancer(CRC)detection.Nevertheless,some conditions could theoretically favour blood originating in proximal areas of the gastrointestinal tract passing through the colon unmetabolized.A positive FIT result could be related to other gastrointestinal cancers(GIC).AIM To assess the risk of GIC detection and related death in FIT-positive symptomatic patients(threshold 10μg Hb/g faeces)without CRC.METHODS Post hoc cohort analysis performed within two prospective diagnostic test studies evaluating the diagnostic accuracy of different FIT analytical systems for CRC and significant colonic lesion detection.Ambulatory patients with gastrointestinal symptoms referred consecutively for colonoscopy from primary and secondary healthcare,underwent a quantitative FIT before undergoing a complete colonoscopy.Patients without CRC were divided into two groups(positive and negative FIT)using the threshold of 10μg Hb/g of faeces and data from follow-up were retrieved from electronic medical records of the public hospitals involved in the research.We determined the cumulative risk of GIC,CRC and upper GIC.Hazard rate(HR)was calculated adjusted by age,sex and presence of significant colonic lesion.RESULTS We included 2709 patients without CRC and a complete baseline colonoscopy,730(26.9%)with FIT≥10μgr Hb/gr.During a mean time of 45.5±20.0 mo,a GIC was detected in 57(2.1%)patients:An upper GIC in 35(1.3%)and a CRC in 14(0.5%).Thirty-six patients(1.3%)died due to GIC:22(0.8%)due to an upper GIC and 9(0.3%)due to CRC.FIT-positive subjects showed a higher CRC risk(HR 3.8,95%CI:1.2-11.9)with no differences in GIC(HR 1.5,95%CI:0.8-2.7)or upper GIC risk(HR 1.0,95%CI:0.5-2.2).Patients with a positive FIT had only an increased risk of CRC-related death(HR 10.8,95%CI:2.1-57.1)and GIC-related death(HR 2.2,95%CI:1.1-4.3),with no differences in upper GIC-related death(HR 1.4,95%CI:0.6-3.3).An upper GIC was detected in 22(0.8%)patients during the first year.Two variables were independently associated:anaemia(OR 5.6,95%CI:2.2-13.9)and age≥70 years(OR 2.7,95%CI:1.1-7.0).CONCLUSION Symptomatic patients without CRC have a moderate risk increase in upper GIC,regardless of the FIT result.Patients with a positive FIT have an increased risk of post-colonoscopy CRC.Noel Pin-Vieito María J Iglesias David Remedios Lorena Rodríguez-Alonso Francisco Rodriguez-Moranta VictoriaÁlvarez-Sánchez Fernando Fernández-Bañares Jaume Boadas Eva Martínez-Bauer Rafael Campo Luis Bujanda Ángel Ferrandez Virginia Piñol Daniel Rodríguez-Alcalde Jordi Guardiola Joaquín Cubiella 2020World Journal of Gastroenterology2020,26,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费